US6121457AExpiredUtility

Compositions and methods using novel substituted imidazolium lipids

61
Assignee: MEGABIOS CORPPriority: Nov 14, 1997Filed: Oct 30, 1998Granted: Sep 19, 2000
Est. expiryNov 14, 2017(expired)· nominal 20-yr term from priority
C07D 233/22C07D 233/24
61
PatentIndex Score
8
Cited by
7
References
22
Claims

Abstract

Compounds of the formula: ##STR1## are provided, in which R 1 and R 2 each independently represent a C 8 -C 24 saturated or unsaturated hydrocarbon chain, which is optionally interrupted by from 1 to 3 heteroatom moieties, such as --O--, --S--, --NH-- and --NR--. The symbol X represents --CH 2 --, --O--, --S--, --NH-- or --NR--. The R group for each of the --NR-- moieties represents an alkyl group having from 1 to 4 carbon atoms. Finally, the subscript n represents the integer 1 or 2, and A - represents an anion, preferably chloride or citrate.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. A compound having the formula: ##STR13## wherein R 1  and R 2  each independently represent a C 8  -C 24  saturated or unsaturated hydrocarbon chain, uninterrupted or interrupted by from 1 to 3 heteroatom moieties selected from the group consisting of --O--, --S--, --NH-- and --NR--; X represents a member selected from the group consisting of --CH 2  --, --O--, --S--, --NH-- and --NR--; wherein R is a lower alkyl group having from 1 to 4 carbon atoms;     n is an integer of from 1 to 2; and   A -   is an anion.   
     
     
       2. A compound of claim 1, wherein R 1  and R 2  each independently represent a C 8  -C 24  saturated or unsaturated hydrocarbon chain. 
     
     
       3. A compound of claim 1, wherein R 1  and R 2  each independently represent a C 12  -C 20  saturated hydrocarbon chain. 
     
     
       4. A compound of claim 1, wherein R 1  and R 2  each independently represent a C 12  -C 20  unsaturated hydrocarbon chain. 
     
     
       5. A compound of claim 1, wherein n is 1. 
     
     
       6. A compound of claim 1, wherein R 1  and R 2  each independently represent a C 12  -C 16  unsaturated hydrocarbon chain, X is --O--, and n is 1. 
     
     
       7. A compound of claim 1, wherein R 1  represents a C 18  -unsaturated hydrocarbon chain, R 2  represents a C 17  unsaturated hydrocarbon chain, X is --O--, and n is 1. 
     
     
       8. A compound of claim 7, wherein R 1  and R 2  each contain a single double bond in the cis orientation. 
     
     
       9. A compound according to claim 1 having the formula: ##STR14##10. 
     
     
       10. A compound according to claim 1 having the formula: 
     
     
       11. A lipid vesicle composition containing a lipid of the formula: wherein R 1  and R 2  each independently represent a C 8  -C 24  saturated or unsaturated hydrocarbon chain, uninterrupted or interrupted by from 1 to 3 heteroatom moieties selected from the group consisting of --O--, --S--, --NH-- and --NR--;   X represents a member selected from the group consisting of --CH 2  --, --O--, --S--, --NH-- and --NR--; wherein R is a lower alkyl group having from 1 to 4 carbon atoms;     n is an integer of from 1 to 2; and   A -   is an anion.   
     
     
       12. A composition of claim 11, wherein R 1  and R 2  each independently represent a C 8  -C 24  saturated or unsaturated hydrocarbon chain. 
     
     
       13. A composition of claim 11, wherein R 1  and R 2  each independently represent a C 12  -C 20  saturated hydrocarbon chain. 
     
     
       14. A composition of claim 11, wherein R 1  and R 2  each independently represent a C 12  -C 20  unsaturated hydrocarbon chain. 
     
     
       15. A composition of claim 11, wherein n is 1. 
     
     
       16. A composition of claim 11, wherein R 1  and R 2  each independently represent a C 12  -C 16  unsaturated hydrocarbon chain, X is --O--, and n is 1. 
     
     
       17. A composition of claim 11, wherein R 1  represents a C 18  -unsaturated hydrocarbon chain, R 2  represents a C 17  unsaturated hydrocarbon chain, X is --O--, and n is 1. 
     
     
       18. A composition of claim 17, wherein R 1  and R 2  each contain a single double bond in the cis orientation. 
     
     
       19. A composition of claim 11, further comprising cholesterol. 
     
     
       20. A composition of claim 11, further comprising dilauroylphosphatidylethanolamine. 
     
     
       21. A composition of claim 11 which is in the form of unilamellar vesicles. 
     
     
       22. A lipid-nucleic acid composition comprising a nucleic acid and a compound of formula: ##STR15## wherein R 1  and R 2  each independently represent a C 8  -C 24  saturated or unsaturated hydrocarbon chain, uninterrupted or interrupted by from 1 to 3 heteroatom moieties selected from the group consisting of --O--, --S--, --NH-- and --NR--; X represents a member selected from the group consisting of --CH 2  --, --O--, --S--, --NH-- and --NR--; wherein R is a lower alkyl group having from 1 to 4 carbon atoms;     n is an integer of from 1 to 2; and   A -   is an anion.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.